Catalyst Wire Dossier Catalyst Wire Dossier

Fenofibrate/Simvastatin 145/40 mg fixed-dose combination

fenofibrate/simvastatin · Abbott
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fenofibrate/Simvastatin 145/40 mg fixed-dose combination, covering 2014-10-30 to 2014-10-30. Get the full timeline:

Most recent: Clinical Trial Update: A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease [Phase 3]

See pricing